Advancing an objective measure of spine fusion
This article was originally published in Start Up
Surgeons would like to know, sooner, rather than later, whether there’s progress toward fusion following spinal fusions. That’s the mission of OrthoData Inc., which is developing an implantable, wireless, microelectronic spine fusion sensor that measures load on the implanted hardware to reveal the fusion status of patients sooner than plain X-rays.
You may also be interested in...
In this week's podcast edition of Five Must-Know Things: landmark results for lecanemab in Alzheimer’s; other Alzheimer’s players rise after the lecanemab results; Leqvio’s importance to Novartis; Pfizer’s secret sauce for digitalization; and Amgen’s clinical trial diversity efforts.
The new ALS product is a fixed-dose combo of two ingredients – sodium phenylbutyrate and taurursodiol – that some patients currently are compounding. Amylyx says it will explore ‘all options’ in addressing that, noting its strong IP for Relyvrio, but also committing to access.
Keeping Track: US FDA Clears Santen’s Omlonti, Fennec’s Pedmark; Lilly’s Retevmo Adds Tumor-Agnostic Claim
The latest drug approval news and highlights from the Pink Sheet’s US FDA Performance Tracker